Plaza Group to Acquire Chemicals Distributor in US
The Plaza Group, a leading international petrochemical marketing firm said that it will acquire Conchemco, a leading marketer and distributor of chemicals and solvents.
Founded in 1990, Conchemco (Dallas, Texas) began as an independent company based on in-home services of buying, selling and brokering chemicals. Through the development of personal relationships with trusted partners, the highest levels of professionalism and the delivery of quality products and exceptional services to clients, it is now a multi-million-dollar company with national distribution. Its core products are acetone, toluene, xylene and other major aromatic and aliphatic hydrocarbons.
“We are excited to be part of a company that shares the common business principles of integrity, quality and a positive outlook on the future of our business,” said Tommy Mrazek, Conchemco owner and CEO.
“The acquisition of Conchemco is a great opportunity to expand our expertise in chemical distribution and marketing, as well as grow our client base. This addition enhances the value of the acquisition and fortifies future growth plans for The Plaza Group,” said Randy Velarde, President and CEO of The Plaza Group.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
From the Brink to the Bend: Bayer’s Q3 2025 Shows Dramatic Loss Reduction—but Crop Science Still Bleeds
-
Growing Pains, But the Roots Are Strong: Corteva Narrows Losses Amid Sales Surge in Q3 2025
-
Profit Soars While Sales Dip: Syngenta Group Defies Headwinds with 28% EBITDA Surge in Q3 2025
-
From Modest Gains to Massive Profits: Nutrien’s Q3 2025 Marks a Stunning Agricultural Comeback
-
Yara’s Green Surge: Record Profits Fuelled by Precision, Not Just Prices
-
Bayer Wins Big on Roundup
-
Syngenta Gets a New Boss
-
The Crop Protection Patent Cliff Is Here
-
Glyphosate Becomes a Trade Fight
-
$15 Billion Invested in China: AstraZeneca Builds an “Innovation Hub” While Some Are Still Waiting for the Windfall
Recommend Reading
-
Covestro CEO: The EU Must Decide Which Industries to Protect, or Energy-Intensive Sectors Will Move Out
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
South Korea’s June Petrochemical Export Value Rises 18.8%, While Export Volume Falls 14.6%
-
Dawn Seizes Strategic Control of EPDM Supply Chain with Acquisition of Ningbo SK—A Bold Leap Toward Global Elasticity
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
Downstream Demand Releases, Formic Acid Prices Steadily Rise
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Business Society’s September 7, 2026 Methanol Market Outlook: Deep Correction
-
Business Society’s September 7, 2026 Melamine Market Outlook: Fluctuating Trend